221 Development of abatacept- and adalimumab-specific predictive models of response to therapy in rheumatoid arthritis using data from a head-to-head study
Clicks: 187
ID: 116722
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.6
/100
12 views
12 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Background: Highly effective, targeted DMARD therapies with different mechanisms of action are available for RA. Translating precision medicine into clinical pr
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (21 words).
Try re-searching for a better abstract.
| Reference Key |
somnath2018rheumatology221 development
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bandyopadhyay, Somnath;Maldonado, Michael A;Ammar, Ron;Schiff, Michael;Weinblatt, Michael;Fleischmann, Roy;Connolly, Sean E; |
| Journal | rheumatology |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.